BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36872414)

  • 1. Nephrotoxicity associated with anticancer agents: perspective on onconephrology from nephrologists.
    Matsubara T; Yokoi H; Yamada H; Yanagita M
    Int J Clin Oncol; 2023 May; 28(5):625-636. PubMed ID: 36872414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticancer Agents-Related Nephrotoxicity].
    Matsubara T
    Gan To Kagaku Ryoho; 2022 Nov; 49(11):1188-1194. PubMed ID: 36412018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
    Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
    Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onconephrology: A New Challenge for the Nephrologist.
    Fofi C; Festuccia F
    Contrib Nephrol; 2021; 199():91-105. PubMed ID: 34375977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations.
    Piscitani L; Sirolli V; Di Liberato L; Morroni M; Bonomini M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer.
    Jagieła J; Bartnicki P; Rysz J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
    McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
    Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes.
    Meraz-Muñoz A; Amir E; Ng P; Avila-Casado C; Ragobar C; Chan C; Kim J; Wald R; Kitchlu A
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32601079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Kidney Injury in Patients With Cancer: A Review of Onconephrology.
    Gudsoorkar P; Langote A; Vaidya P; Meraz-Muñoz AY
    Adv Chronic Kidney Dis; 2021 Sep; 28(5):394-401.e1. PubMed ID: 35190106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute kidney injury in cancer patients.
    Liu S; Zhao J; Wang F
    Clin Exp Nephrol; 2022 Feb; 26(2):103-112. PubMed ID: 34499266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the nephrotoxicity of novel anticancer agents
.
    Nussbaum EZ; Perazella MA
    Clin Nephrol; 2018 Mar; 89(3):149-165. PubMed ID: 29350175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onconephrology: The intersections between the kidney and cancer.
    Rosner MH; Jhaveri KD; McMahon BA; Perazella MA
    CA Cancer J Clin; 2021 Jan; 71(1):47-77. PubMed ID: 32853404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrotoxicity--proteinuria and hypertension--].
    Ando M
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1649-53. PubMed ID: 18931564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-cancer agents nephrotoxicity].
    Mieczkowski M; Matuszkiewicz-Rowińska J; Kościelska M
    Wiad Lek; 2015; 68(4 Pt 2):650-4. PubMed ID: 27162304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onconephrology: mitigation of renal injury in chemotherapy administration.
    Selamet U; Ahdoot RS; Salasnek R; Abdelnour L; Hanna RM
    Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):257-266. PubMed ID: 38095483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onconephrology: What Should the Internist Know About Targeted Therapy in Solid Tumors?
    El Rassy E; El Karak F; Rizkallah J; Chelala D
    Iran J Kidney Dis; 2016 Jul; 10(4):169-75. PubMed ID: 27514761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between kidney disease and cancer: complications and treatment.
    Malyszko J; Tesarova P; Capasso G; Capasso A
    Lancet; 2020 Jul; 396(10246):277-287. PubMed ID: 32711803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
    Cortazar FB; Marrone KA; Troxell ML; Ralto KM; Hoenig MP; Brahmer JR; Le DT; Lipson EJ; Glezerman IG; Wolchok J; Cornell LD; Feldman P; Stokes MB; Zapata SA; Hodi FS; Ott PA; Yamashita M; Leaf DE
    Kidney Int; 2016 Sep; 90(3):638-47. PubMed ID: 27282937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of Antimicrobials and Antibiotics.
    Morales-Alvarez MC
    Adv Chronic Kidney Dis; 2020 Jan; 27(1):31-37. PubMed ID: 32146999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal toxicity of antineoplasic agents].
    Garcia H; Teuma C; Languille E
    Rev Prat; 2021 Feb; 71(2):193-197. PubMed ID: 34160983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.